RAMM Pharma

RAMM Pharma Days Payable Outstanding

The Days Payable Outstanding (DPO) of RAMM Pharma (RAMM.CN) as of Oct 31, 2026 is 60.67. In the previous year, Days Payable Outstanding (DPO) was 91.23 — a change of -33.49% (lower).

Days Payable Outstanding

60.67

YoY

-33.49%

Last updated:

Days Payable Outstanding (DPO) of RAMM Pharma is 2025 60.67 . Days Payable Outstanding (DPO) of RAMM Pharma was 2024 91.23 . It decreases by -33.49% lower compared to the previous year.

The RAMM Pharma Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
82.71 CAD
Jan 1, 2019
99.66 CAD
Jan 1, 2020
44.18 CAD
Jan 1, 2021
170.88 CAD
Jan 1, 2022
126.99 CAD
Jan 1, 2023
94.91 CAD
Jan 1, 2024
91.23 CAD
Jan 1, 2025
60.67 CAD
The RAMM Pharma Days Payable Outstanding history
YEARDays Payable OutstandingYoY
60.67-33.49%
91.23-3.88%
94.91-25.26%
126.99-25.69%
170.88+286.76%
44.18-55.67%
99.66+20.49%
82.71—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp generates revenue through cannabinoid pharmaceuticals and cannabis-based products, with brands like NettaLife, NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet targeting pet owners and veterinary markets. The company also sells cosmetics under the Cannabipiel line, including Cannabipiel Nite, Cannabipiel Body Lotion, and Cannabipiel Shampoo, catering to consumers seeking cannabinoid-infused skincare and personal care solutions. Subsidiaries such as Canapar Corp. and Medic Plast SA support production and commercialization across pharmaceutical specialties, household products, and food sectors. The firm’s product portfolio spans pharmaceuticals, pet care, cosmetics, and household items, with NettaPet and NettaVet focusing on animal health and Cannabipiel products targeting human skincare. Revenue streams include direct sales of branded items like Cannabipiel Tite and Cannabipiel Cleaning Emulsion to retail and specialty markets, while subsidiaries handle manufacturing and export operations for global distribution. Brands like Glediser SA and Yurelan SA contribute to the commercialization of diverse product categories under the company’s umbrella. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

Days Payable Outstanding (DPO) of RAMM Pharma is 60.67 in 2025.

Days Payable Outstanding (DPO) of RAMM Pharma changed from 91.23 to 60.67, representing a -33.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s RAMM Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — RAMM Pharma

All Key Metrics — RAMM Pharma